Sign In
Buy TTI
$9.73
-1.16 (-10.65%)
At Close: Jun 03, 2026
Thiogenesis Closes Oversubscribed Non-Brokered Private Placement for Gross Proceeds of C$9.07 Million
06:00am, Wednesday, 03'rd Jun 2026
San Diego, California--(Newsfile Corp. - June 3, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing a next-generatio
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock
12:00am, Wednesday, 03'rd Jun 2026
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock PR Newswire SPRING, Texas, June 2,
TETRA Technologies, Inc. Announces Pricing of Public Offering of Common Stock
11:36pm, Tuesday, 02'nd Jun 2026
SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announced the pricing of an underwritten public offering of 10,810,811 shares of its c
TETRA TECHNOLOGIES, INC. ANNOUNCES PUBLIC OFFERING OF COMMON STOCK
04:05pm, Tuesday, 02'nd Jun 2026
SPRING, Texas, June 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announced the commencement of an underwritten public offering of $100 million of share
Thiogenesis Upsizes Non-Brokered Private Placement of Common Shares
02:49pm, Monday, 01'st Jun 2026
San Diego, California--(Newsfile Corp. - June 1, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing
TETRA TECHNOLOGIES, INC. BOARD OF DIRECTORS APPROVES FINAL INVESTMENT DECISION FOR ARKANSAS BROMINE PRODUCTION FACILITY
05:30pm, Thursday, 28'th May 2026
Strong Project Economics and Growth Outlook With a Secure U.S. Bromine Supply SPRING, Texas, May 28, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) today announc
Thiogenesis Announces Non-Brokered Private Placement
09:00am, Monday, 11'th May 2026
San Diego, California--(Newsfile Corp. - May 11, 2026) - Thiogenesis Therapeutics Corp. (TSXV: TTI) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing a next-generatio
TETRA Technologies: Deep In The Oil Patch, A Critical Minerals Play Is Taking Shape
02:20am, Monday, 11'th May 2026
TETRA Technologies reported decade-high Q1 2026 revenue and EBITDA, with EPS coming 100% above estimates despite flat year-over-year growth. The company is constructing an Arkansas bromine facility fo
Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update
07:00am, Friday, 08'th May 2026
Topline results from healthy volunteer study and clinical development strategy for next-generation STAT3 inhibitor, TTI-109, anticipated in June Topline data from Phase 2 trial of TTI-101 in hepatoc
TETRA Technologies, Inc. (TTI) Q1 2026 Earnings Call Transcript
06:01pm, Thursday, 30'th Apr 2026
TETRA Technologies, Inc. (TTI) Q1 2026 Earnings Call Transcript
Tetra Technologies (TTI) Q1 Earnings and Revenues Top Estimates
07:41pm, Wednesday, 29'th Apr 2026
Tetra Technologies (TTI) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.11 per share a year ago.
TETRA TECHNOLOGIES, INC. REPORTS STRONG FIRST-QUARTER 2026 RESULTS MAINTAINS 2026 GUIDANCE
05:00pm, Wednesday, 29'th Apr 2026
SPRING, Texas, April 29, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE:TTI) announced financial results for the three months ended March 31, 2026. First-Quarter 2026
Analysts Estimate Tetra Technologies (TTI) to Report a Decline in Earnings: What to Look Out for
11:02am, Wednesday, 22'nd Apr 2026
Tetra Technologies (TTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Thiogenesis Therapeutics to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference
09:00am, Thursday, 16'th Apr 2026
San Diego, California--(Newsfile Corp. - April 16, 2026) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company") a clinical-stage biopharmaceutical company develo
TETRA TECHNOLOGIES, INC. ANNOUNCES DATE FOR FIRST QUARTER 2026 EARNINGS CONFERENCE CALL
06:34pm, Tuesday, 07'th Apr 2026
SPRING, Texas, April 7, 2026 /PRNewswire/ -- TETRA Technologies, Inc. (NYSE:TTI) will release First Quarter 2026 results after the market closes on April 29, 2026. Brady Murphy, President and CEO, an
